Int J Environ Res Public Health:青少年特应性皮炎患者的峰值运动负荷能力和运动量低于未患皮炎的青少年

2022-09-05 医路坦克 MedSci原创

背景:运动引起的出汗和皮温升高会降低特应性皮炎青少年的体力活动和运动意愿。本研究旨在调查青少年特应性皮炎患者的运动负荷能力,并对其运动行为和动机进行分析。

特应性皮炎(AD)是一种慢性炎症性皮肤病,通常发生在儿童早期。AD的致病因素,导致免疫功能紊乱,可能与基因、免疫系统和环境的相互作用有关。AD的主要症状包括面部、颈部和四肢的湿疹、瘙痒和反复发作的炎症。

青春期的体育锻炼有助于养成健康的生活方式,这种生活方式可以持续到成年,并能降低慢性病的发病率。然而,运动引起的出汗和皮肤温度的升高会加剧AD的症状,从而降低这一患者群体的运动意愿和运动量从长远来看,缺乏体育锻炼会对健康产生负面影响,很少有研究调查患有AD的青少年的运动行为。本研究的目的是调查AD青少年的运动负荷能力、常规运动量、动机和自我效能感。

方法:将有特应性皮炎和无特应性皮炎的青少年分为特应性皮炎组和对照组各27例。两组都完成了心肺运动测试和问卷调查,以分别评估他们的运动量、每周运动量、运动动机和自我效能。

结果:特应性皮炎组的用力肺活量与预计用力肺活量的比值及最大耗氧量均显著低于对照组。特应性皮炎组的Godin休闲时间运动问卷得分显著低于对照组。特应性皮炎组在运动行为规范问卷2中,注入规则和识别规则得分显著低于对照组。在锻炼多维度自我效能感方面,特应性皮炎组的时间安排效能感和总分显著低于对照组。

每组参与者的一般特征

各组CPET结果

各组戈丁闲暇时间锻炼问卷、BREQ-2和锻炼量表多维度自我效能感测查结果

结论:与未受影响的同龄人相比,患有AD的青少年峰值运动负荷能力、FVC%和每周运动量较低,对不活动的负面情绪较少,对定期运动好处的积极认识较少,运动自我效能感较低,对定期运动计划的自信心较低。结果表明,医生和家长应鼓励青少年AD患者在室内锻炼

文献来源: Yang TH,  Chen PC,  Lin YC,Adolescents with Atopic Dermatitis Have Lower Peak Exercise Load Capacity and Exercise Volume Compared with Unaffected Peers.Int J Environ Res Public Health 2022 Aug 18;19(16)

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2059229, encodeId=bbf42059229bd, content=<a href='/topic/show?id=739f94235ce' target=_blank style='color:#2F92EE;'>#运动量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94235, encryptionId=739f94235ce, topicName=运动量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Wed Nov 16 17:37:06 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861516, encodeId=8b20186151616, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Jan 10 14:37:06 CST 2023, time=2023-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524345, encodeId=a0221524345fb, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Tue Sep 06 08:37:06 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621964, encodeId=9b491621964c4, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Tue Sep 06 08:37:06 CST 2022, time=2022-09-06, status=1, ipAttribution=)]
    2022-11-16 xuyu
  2. [GetPortalCommentsPageByObjectIdResponse(id=2059229, encodeId=bbf42059229bd, content=<a href='/topic/show?id=739f94235ce' target=_blank style='color:#2F92EE;'>#运动量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94235, encryptionId=739f94235ce, topicName=运动量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Wed Nov 16 17:37:06 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861516, encodeId=8b20186151616, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Jan 10 14:37:06 CST 2023, time=2023-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524345, encodeId=a0221524345fb, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Tue Sep 06 08:37:06 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621964, encodeId=9b491621964c4, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Tue Sep 06 08:37:06 CST 2022, time=2022-09-06, status=1, ipAttribution=)]
    2023-01-10 shizhenshan
  3. [GetPortalCommentsPageByObjectIdResponse(id=2059229, encodeId=bbf42059229bd, content=<a href='/topic/show?id=739f94235ce' target=_blank style='color:#2F92EE;'>#运动量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94235, encryptionId=739f94235ce, topicName=运动量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Wed Nov 16 17:37:06 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861516, encodeId=8b20186151616, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Jan 10 14:37:06 CST 2023, time=2023-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524345, encodeId=a0221524345fb, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Tue Sep 06 08:37:06 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621964, encodeId=9b491621964c4, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Tue Sep 06 08:37:06 CST 2022, time=2022-09-06, status=1, ipAttribution=)]
    2022-09-06 july_979
  4. [GetPortalCommentsPageByObjectIdResponse(id=2059229, encodeId=bbf42059229bd, content=<a href='/topic/show?id=739f94235ce' target=_blank style='color:#2F92EE;'>#运动量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94235, encryptionId=739f94235ce, topicName=运动量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Wed Nov 16 17:37:06 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861516, encodeId=8b20186151616, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Jan 10 14:37:06 CST 2023, time=2023-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524345, encodeId=a0221524345fb, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Tue Sep 06 08:37:06 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621964, encodeId=9b491621964c4, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Tue Sep 06 08:37:06 CST 2022, time=2022-09-06, status=1, ipAttribution=)]

相关资讯

Hypertension:运动量与老年高血压人群死亡率较低有关

美国一项研究表明,运动量与老年高血压人群死亡率较低具有相关性。相关论文5月12日在线发表于《高血压》(HYPERTENSION)杂志。 该研究共纳入2153例年龄≥70岁的男性高血压受试者,对其进行常规运动耐力测试。在代谢当量中评估其峰值运动量。校正年龄后,基于MET峰值确定其健康类别,极低、低、中和高健康水平受试者的MET分别为2.0 —4.0、4.1—6.0、6.1 —8.0和>8.0

Circulation:运动员终身运动量与冠脉粥样硬化的关系

> 2000 MET-min /周组CAC和动脉粥样硬化斑块的患病率较高。然而,运动最多组具有更良性的斑块组成,混合斑块较少,更常见仅钙化斑块。

Br J Sports Med:多少运动量,可以抵消掉10小时久坐带来的健康危害

众所周知,久坐不动会给身体带来各种健康风险。此前一项荟萃分析表明,每天需要60到75分钟的中到高强度运动才能抵消掉与久坐相关的死亡风险。但每天单独拿出60分钟运动,恐怕很少有人能做到吧?

Circulation:TAVR术前后运动量的变化与临床预后的相关性研究

经皮主动脉瓣置换术(TAVR)是治疗主动脉瓣疾病最有效的方案之一。近日,在国际心血管权威杂志《Circulation》上发表了一篇关于探索TAVR术后不同的运动量对预后影响的临床研究。

JAMA:有氧训练可改善超重或肥胖儿童的健康状况

为了检测不同有氧运动量对胰岛素抵抗,肥胖,内脏脂肪,超重健康因素,欠缺运动儿童健康的影响,以及性别和种族在其中的起到了怎样的作用,美国乔治亚州医学院公共健康与预防中心Catherine L. Davis博士等人的进行了深入研究,他们发现经过13周的20或40 min/d 的有氧训练可改善欠缺运动的超重或肥胖儿童的肥胖或内脏肥胖健康状况,并证实其胰岛素抵抗受益有运动量反应性。相关论文发表于国际权威杂